Inventor
LAURENT ALAIN
CA38 patents
⚠️ This page may combine multiple inventors who share the name “LAURENT ALAIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LAURENT ALAIN
9 patentsUS4994509AFeb 19, 1991
Multicolored compound for wall coating
LAURENT ALAIN7 citations73
US8063095B2Nov 22, 2011
IAP BIR domain binding compounds
LAURENT ALAIN6 citations71
US8163792B2Apr 24, 2012
IAP BIR domain binding compounds
LAURENT ALAIN3 citations60
US8648094B2Feb 11, 2014
IAP BIR domain binding compounds
LAURENT ALAIN0 citations50
US8309695B2Nov 13, 2012
Marking reagents bearing diazo and nitro functions, methods for the synthesis of such reagents and methods for detecting biological molecules
LAURENT ALAIN0 citations50
US9266902B2Feb 23, 2016
Labelling reagents having a pyridine nucleus bearing a diazomethyl function, process for synthesis of such reagents and processes for detection of biological molecules
LAURENT ALAIN0 citations44
US9624239B2Apr 18, 2017
Protein kinase inhibitors
LAURENT ALAIN0 citations39
US9284318B2Mar 15, 2016
Protein kinase inhibitors
LAURENT ALAIN0 citations39
US9284350B2Mar 15, 2016
IAP BIR domain binding compounds
LAURENT ALAIN0 citations33
AEGERA THERAPEUTICS INC
7 patentsUS7579320B2Aug 25, 2009
IAP BIR domain binding compounds
AEGERA THERAPEUTICS INC41 citations95
US7589118B2Sep 15, 2009
IAP BIR domain binding compounds
AEGERA THERAPEUTICS INC40 citations94
US7645741B2Jan 12, 2010
IAP BIR domain binding compounds
AEGERA THERAPEUTICS INC9 citations83
US7772177B2Aug 10, 2010
BIR domain binding compounds
AEGERA THERAPEUTICS INC16 citations81
US7547724B2Jun 16, 2009
IAP BIR domain binding compounds
AEGERA THERAPEUTICS INC12 citations81
US7129250B2Oct 31, 2006
Neuroprotective and anti-proliferative compounds
AEGERA THERAPEUTICS INC7 citations61
US7795298B2Sep 14, 2010
IAP BIR domain binding compounds
AEGERA THERAPEUTICS INC1 citations60
PHARMASCIENCE INC
6 patentsUS9447102B2Sep 20, 2016
Protein kinase inhibitors
PHARMASCIENCE INC2 citations60
US9365614B2Jun 14, 2016
IAP BIR domain binding compounds
PHARMASCIENCE INC0 citations51
US8765681B2Jul 1, 2014
IAP BIR domain binding compounds
PHARMASCIENCE INC0 citations51
US9822120B2Nov 21, 2017
Protein kinase inhibitors
PHARMASCIENCE INC1 citations50
US9795608B2Oct 24, 2017
Protein kinase inhibitors
PHARMASCIENCE INC0 citations50
US9796716B2Oct 24, 2017
Selective inhibitors of Tec and Src protein kinase families
PHARMASCIENCE INC0 citations39
BIOMERIEUX SA
6 patentsUS12264312B2Apr 1, 2025
Method for extracting nucleic acids
BIOMERIEUX SA0 citations56
US11708375B2Jul 25, 2023
Reagents for reversibly protecting biological molecules
BIOMERIEUX SA1 citations55
US9464308B2Oct 11, 2016
Method for transcriptional amplification of nucleic acids combining steps of different temperatures
BIOMERIEUX SA0 citations49
US7446186B2Nov 4, 2008
Pyrroles substituted by oligonucleotides
BIOMERIEUX SA1 citations47
US10752892B2Aug 25, 2020
Multilayer complex, method for manufacturing said complex and use of said complex
BIOMERIEUX SA0 citations43
US10174068B2Jan 8, 2019
Methods of functionalization and reagents used in such methods using an aza-isatoic anhydride or a derivative thereof, biological molecules thus treated and kits
BIOMERIEUX SA0 citations42
NOVARTIS AG
4 patentsUS7268189B2Sep 11, 2007
Polymers
NOVARTIS AG130 citations98
US7238750B2Jul 3, 2007
Polymers
NOVARTIS AG147 citations98
US7091283B2Aug 15, 2006
Crosslinkable prepolymers from a hydrophilic monomer and a hydrophobic crosslinker
NOVARTIS AG186 citations98
US7566754B2Jul 28, 2009
Process for making contact lenses from prepolymers
NOVARTIS AG23 citations92